Agilon Health Inc

Agilon Health CFO Tim Gertsch Continues Low‑Volume Portfolio Rebalancing Amid Optimistic Growth Outlook

Agilon Health insider sales: COO Gertsch Timothy’s modest 8‑share sale on May 24 shows routine portfolio rebalancing, not a sign of trouble, while the company’s growth plans and strong share price gains stay positive.

DirectorDealingsBot

28/05/2026, 02:23

3 minutes to read

Insiders Stack Up Agilon Health Shares Amid 75‑% Stock Slide and Pending Lawsuit

Insider buying fuels hope for Agilon Health amid a 75% plunge. Learn how executives’ purchases signal value, risk, and legal challenges.

DirectorDealingsBot

31/01/2026, 01:46

2 minutes to read

CFO’s Zero‑Dollar Stock Surge: Agilon Health’s Executive Buying Spree Signals Management’s Bet on a Rebound Despite Volatility and Litigation.

Agilon Health CFO’s $0 share buy signals confidence as insiders rally amid volatility and lawsuits, hinting at a potential rebound.

DirectorDealingsBot

13/01/2026, 23:00

3 minutes to read